Digital health pioneer files for bankruptcy; new AI tool aims to help surgeons quickly analyze brain tumors

The road has run out for Pear Therapeutics: the pioneering digital therapeutics company filed for chapter 11 bankruptcy on Friday.

April 7, 2023 Check out STAT+

Sponsored By

Jim Mone/AP STAT+ | Wall Street embraces health insurers after scoring Medicare Advantage payment win Insurers in Medicare Advantage will retain billions in extra taxpayer dollars next year, after the Biden administration delayed reforms. By Bob Herman STAT+ | A new AI tool aims to help surgeons quickly analyze brain tumor mutations during surgery A new AI tool called DeepGlioma aims to dramatically speed up the process of testing brain tumors called gliomas for genetic mutations. By Brittany Trang STAT+ | Digital health pioneer Pear Therapeutics files for bankruptcy The road has run out for Pear Therapeutics: the pioneering digital therapeutics company filed for chapter 11 bankruptcy on Friday and will seek to sell off its assets to pay back its creditors. Pear will terminate 170 employees, or approximately 92% of its workforce, and will continue to operate in limited capacity with 15 employees as it seeks a buyer. CEO Corey McCann has stepped down from his role, but will continue to serve on the company's board and will provide consulting services. By Mario Aguilar Adobe Opinion: I declined to share my medical data with advertisers at my doctor's office. One company claimed otherwise I spent much of my maternity leave trying to figure out why my doctors were trying to give my medical data away to advertisers. By Alex R. Rosenblat STAT+ | Liver disease researchers are hoping AI can improve their trial design NASH and liver fibrosis are driven by a "multi-modal conspiracy"; the hope is that tools like ChatGPT can see patterns a human would miss. By Isabella Cueto STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser